ArticleScreening for Symptomatic Mefloquine Exposure Among Veterans With Chronic Psychiatric SymptomsAuthor:Remington L. Nevin, MD, MPH, DrPHPublish date: March 7, 2017Mefloquine is an antimalarial drug that is associated with a significant risk of chronic neuropsychiatric adverse effects (AEs). The drug was licen...Read More
ArticleFDA Black Box, VA Red Ink? A Successful Service-Connected Disability Claim for Chronic Neuropsychiatric Adverse Effects From MefloquineAuthor:Remington L. Nevin, MD, MPH, DrPHPublish date: October 14, 2016More veterans are likely to present to the VA with service-connected claims for adverse effects related to exposure to a prophylactic antimalarial ...Read More
